EUR 41.3
(-2.59%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 657.88 Million EUR | -4.16% |
2022 | 686.46 Million EUR | 12.55% |
2021 | 609.93 Million EUR | -0.88% |
2020 | 615.36 Million EUR | 27.76% |
2019 | 481.64 Million EUR | 5.65% |
2018 | 455.9 Million EUR | 18.23% |
2017 | 385.61 Million EUR | 0.34% |
2016 | 384.29 Million EUR | -3.76% |
2015 | 399.31 Million EUR | 3.2% |
2014 | 386.92 Million EUR | 4.4% |
2013 | 370.62 Million EUR | 2.44% |
2012 | 361.81 Million EUR | 6.32% |
2011 | 340.29 Million EUR | -4.59% |
2010 | 356.66 Million EUR | 18.91% |
2009 | 299.94 Million EUR | -8.84% |
2008 | 329.02 Million EUR | 6.77% |
2007 | 308.16 Million EUR | 6.53% |
2006 | 289.27 Million EUR | 0.14% |
2005 | 288.88 Million EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 706.87 Million EUR | 7.45% |
2024 Q2 | 721.29 Million EUR | 2.04% |
2023 Q4 | 657.88 Million EUR | -15.79% |
2023 Q3 | 781.24 Million EUR | 2.38% |
2023 Q2 | 763.09 Million EUR | 1.76% |
2023 FY | 657.88 Million EUR | -4.16% |
2023 Q1 | 749.88 Million EUR | 9.24% |
2022 Q1 | 675.54 Million EUR | 10.76% |
2022 FY | 686.46 Million EUR | 12.55% |
2022 Q4 | 686.46 Million EUR | -13.88% |
2022 Q3 | 797.12 Million EUR | 9.51% |
2022 Q2 | 727.93 Million EUR | 7.75% |
2021 Q1 | 694.21 Million EUR | 12.81% |
2021 FY | 609.93 Million EUR | -0.88% |
2021 Q2 | 676.45 Million EUR | -2.56% |
2021 Q3 | 689.96 Million EUR | 2.0% |
2021 Q4 | 609.93 Million EUR | -11.6% |
2020 FY | 615.36 Million EUR | 27.76% |
2020 Q4 | 615.36 Million EUR | -12.57% |
2020 Q1 | 532.81 Million EUR | 10.62% |
2020 Q2 | 642.06 Million EUR | 20.5% |
2020 Q3 | 703.86 Million EUR | 9.63% |
2019 Q4 | 481.64 Million EUR | -13.42% |
2019 Q1 | 507.46 Million EUR | 11.31% |
2019 Q2 | 518.45 Million EUR | 2.17% |
2019 FY | 481.64 Million EUR | 5.65% |
2019 Q3 | 556.29 Million EUR | 7.3% |
2018 Q3 | 512.9 Million EUR | 9.54% |
2018 FY | 455.9 Million EUR | 18.23% |
2018 Q2 | 468.21 Million EUR | 3.13% |
2018 Q1 | 453.99 Million EUR | 17.73% |
2018 Q4 | 455.9 Million EUR | -11.11% |
2017 Q4 | 385.61 Million EUR | -14.59% |
2017 FY | 385.61 Million EUR | 0.34% |
2017 Q3 | 451.5 Million EUR | 5.04% |
2017 Q2 | 429.84 Million EUR | -0.21% |
2017 Q1 | 430.75 Million EUR | 12.09% |
2016 FY | 384.29 Million EUR | -3.76% |
2016 Q1 | 415.31 Million EUR | 4.01% |
2016 Q3 | 457.61 Million EUR | 4.85% |
2016 Q2 | 436.44 Million EUR | 5.09% |
2016 Q4 | 384.29 Million EUR | -16.02% |
2015 Q2 | 459.04 Million EUR | -0.98% |
2015 Q1 | 463.59 Million EUR | 19.81% |
2015 FY | 399.31 Million EUR | 3.2% |
2015 Q4 | 399.31 Million EUR | -13.87% |
2015 Q3 | 463.6 Million EUR | 0.99% |
2014 Q2 | 404.52 Million EUR | 0.42% |
2014 Q4 | 386.92 Million EUR | -11.35% |
2014 Q3 | 436.48 Million EUR | 7.9% |
2014 Q1 | 402.84 Million EUR | 8.69% |
2014 FY | 386.92 Million EUR | 4.4% |
2013 FY | 370.62 Million EUR | 2.44% |
2013 Q4 | 370.62 Million EUR | -11.95% |
2013 Q3 | 420.95 Million EUR | 5.72% |
2013 Q2 | 398.17 Million EUR | -0.21% |
2013 Q1 | 399.02 Million EUR | 10.29% |
2012 Q4 | 361.81 Million EUR | -9.59% |
2012 Q1 | 364.4 Million EUR | 7.09% |
2012 Q2 | 390.2 Million EUR | 7.08% |
2012 FY | 361.81 Million EUR | 6.32% |
2012 Q3 | 400.21 Million EUR | 2.56% |
2011 Q2 | 362.15 Million EUR | -1.83% |
2011 Q1 | 368.89 Million EUR | 3.43% |
2011 Q3 | 383.68 Million EUR | 5.94% |
2011 Q4 | 340.29 Million EUR | -11.31% |
2011 FY | 340.29 Million EUR | -4.59% |
2010 Q1 | 354.95 Million EUR | 18.34% |
2010 FY | 356.66 Million EUR | 18.91% |
2010 Q4 | 356.66 Million EUR | -3.01% |
2010 Q3 | 367.71 Million EUR | -0.53% |
2010 Q2 | 369.67 Million EUR | 4.15% |
2009 Q4 | 299.94 Million EUR | 0.0% |
2009 FY | 299.94 Million EUR | -8.84% |
2008 FY | 329.02 Million EUR | 6.77% |
2007 FY | 308.16 Million EUR | 6.53% |
2006 FY | 289.27 Million EUR | 0.14% |
2005 FY | 288.88 Million EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cegedim SA | 9.2 Million EUR | -7050.19% |
Guerbet SA | 305.17 Million EUR | -115.576% |
Nexus AG | 3.22 Million EUR | -20287.016% |
Bastide Le Confort Médical SA | 43.2 Million EUR | -1422.644% |
Revenio Group Oyj | 10.5 Million EUR | -6165.61% |
Sartorius Aktiengesellschaft | 1.03 Billion EUR | 36.54% |
LNA Santé SA | 148.29 Million EUR | -343.626% |
Siemens Healthineers AG | 4.26 Billion EUR | 84.56% |
Medios AG | 60.43 Million EUR | -988.553% |
Equasens Société anonyme | 10.31 Million EUR | -6278.602% |
Stratec SE | 142.62 Million EUR | -361.272% |